From prostate-specific antigen to precision: The future of prostate cancer diagnosis with artificial intelligence, biomarkers, and imaging

Background:. Prostate cancer (PCa) diagnosis has historically relied on prostate-specific antigen (PSA) testing. Although PSA screening significantly reduces mortality rates, it is limited by its low specificity and the risk of overdiagnosis and overtreatment. These limitations highlight the need fo...

Полное описание

Библиографические подробности

Главные авторы:	Helena Margot Flôres Soares da Silva, Juan Gómez Rivas, Paula Mata Déniz, María Jesús Marugan, Claudia González-Santander, Lorena Fernández Montarroso, Isabel Galante, Jesús Moreno Sierra
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wolters Kluwer Health 2026-05-01
Серии:	Current Urology
Online-ссылка:	http://journals.lww.com/10.1097/CU9.0000000000000326
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!